[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359176-105":59,"doc-detail-359176-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mcm8-promotes-colorectal-cancer-progression-by-competitively-inhibiting-hrd1-mediated-cdc42-ubiquitination-and-degradation","MCM8 promotes colorectal cancer progression by competitively inhibiting HRD1-mediated CDC42 ubiquitination and degradation","","Minichromosomal maintenance protein 8 (MCM8) is frequently abnormally overexpressed in cancers, yet its role in colorectal cancer (CRC) progression and chemotherapy resistance remains unclear. This study measured MCM8 expression in CRC tissues and cells, linked it to clinicopathological features and prognosis, and used cellular, protein-interaction, and in vivo tumorigenesis assays. MCM8 enhanced G1-to-S cell-cycle transition and stabilized CDC42 by competitively blocking HRD1-mediated ubiquitination, promoting proliferation, invasion, and 5-FU resistance while suppressing apoptosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mcm8-promotes-colorectal-cancer-progression-by-competitively-inhibiting-hrd1-mediated-cdc42-ubiquitination-and-degradation/359176/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mcm8-promotes-colorectal-cancer-progression-by-competitively-inhibiting-hrd1-mediated-cdc42-ubiquitination-and-degradation/359176.png","ImageObject",300,407,{"name":92,"@type":93},"Margaret","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study propose about MCM8 in colorectal cancer?","Question",{"text":112,"@type":113},"MCM8 is proposed to be abnormally overexpressed in CRC and to promote tumor progression and 5-FU resistance by stabilizing CDC42.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the role of MCM8 investigated?",{"text":117,"@type":113},"The study assessed MCM8 expression in CRC tissues and cells, correlated it with clinical features and prognosis, and performed cell function assays, protein-protein interaction validation, and in vivo tumorigenesis experiments.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular mechanism connects MCM8 to CDC42 and drug resistance?",{"text":121,"@type":113},"MCM8 interacts with CDC42 and increases its protein stability by competitively inhibiting HRD1-mediated ubiquitination, thereby promoting CRC development and 5-FU resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359176,1790196763,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Qian et al. Journal of Translational Medicine (2026) 24:408  \n[https://doi.org/10.1186/s12967-026-07687-0](https://doi.org/10.1186/s12967-026-07687-0)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nMCM8 promotes colorectal cancer progression by competitively inhibiting HRD1-mediated CDC42 ubiquitination and degradation  \nSiyi Qian1,2†, Longwu Zeng3†, Fuxin Chen2, Yuxuan Tian2, Binjie Zhao2, Qiang Liu1* and Bin Zhang2*  \nAbstract  \nBackground Colorectal cancer (CRC) ranks among the top three in both incidence and mortality rates of malignant tumors worldwide. For patients with advanced colon cancer, radical surgery is challenging, and chemotherapy drugs are prone to inducing drug resistance, resulting in a five-year survival rate of only 13. 1% . Therefore, in-depth analysis of the occurrence, development, and drug resistance mechanisms of colon cancer is of great clinical significance for optimizing treatment strategies and improving patient prognosis. As one of the homologous recombination repair proteins, minichromosomal maintenance protein 8 (MCM8) not only participates in DNA replication initiation, homologous recombination repair, and genome stability maintenance in normal cells, but also has been reported to be abnormally highly expressed in multiple tumors (e. g. glioblastoma, cholangiocarcinoma, bladder cancer) to promote malignant progression.  \nMethods This study focused on the expression and function of MCM8 in colon cancer. The expression level of MCM8 in colon cancer tissues and cells was detected, and its correlation with patients’ clinicopathological features and prognosis was analyzed. Combined with cell function experiments, protein-protein interaction verification assays, and in vivo tumorigenesis experiments, the effects of MCM8 on the biological behaviors of colon cancer cells and the underlying molecular mechanisms were explored. Meanwhile, rescue experiments were conducted to identify the key downstream molecules and pathways mediated by MCM8 . Additionally, the relationship between MCM8 and chemoresistance of colon cancer cells was investigated.  \nResults Our study indicated that MCM8 promotes the transition of the cell cycle from the G1 phase to the S phase in CRC cell lines(SW620, HCT116, CX-1) . Moreover, our study showed that MCM8 interacted with Cdc42(Cell Division Cycle 42) and promoted its protein stability by competitively inhibiting the ubiquitination modification of Cdc42‘s E3 ubiquitin ligase HRD1(Hydroxymethylglutaryl Reductase Degradation Protein 1) . The rescue experiment showed  \n†Siyi Qian and Longwu Zeng are co-first authors who made equally significant contributions to this work.  \n*Correspondence:  \nQiang Liu [Liuqiang1501@hnca.org.cn](Liuqiang1501@hnca.org.cn)[ ](Liuqiang1501@hnca.org.cn)Bin Zhang [zhangbinketizu@163.com](zhangbinketizu@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons","cbCaipDR6pev2Tuc","https://ap.wps.com/l/cbCaipDR6pev2Tuc","pdf",9770815,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What does the study propose about MCM8 in colorectal cancer?\",\"answer\":\"MCM8 is proposed to be abnormally overexpressed in CRC and to promote tumor progression and 5-FU resistance by stabilizing CDC42.\"},{\"question\":\"How was the role of MCM8 investigated?\",\"answer\":\"The study assessed MCM8 expression in CRC tissues and cells, correlated it with clinical features and prognosis, and performed cell function assays, protein-protein interaction validation, and in vivo tumorigenesis experiments.\"},{\"question\":\"What molecular mechanism connects MCM8 to CDC42 and drug resistance?\",\"answer\":\"MCM8 interacts with CDC42 and increases its protein stability by competitively inhibiting HRD1-mediated ubiquitination, thereby promoting CRC development and 5-FU resistance.\"}]","MCM8 promotes colorectal cancer progression by competitively inhibiting HRD1-mediated CDC42 ubiquitination and degradation | PDF",1790136339,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b38b5fbaed5aad130384e607c6c3616.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf2390fef8561bd602173e23f0a8f68e.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05cac42a851e2c5a615e21747f6ea44f.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52994bcf9d1dbff438855960ba969e0b.webp",980,1306]